DD:NYE-E.I. du Pont de Nemours and Company (USD)

EQUITY | Specialty Chemicals | New York Stock Exchange

Last Closing

USD 78.35

Change

-0.52 (-0.66)%

Market Cap

USD 61.52B

Volume

1.34M

Analyst Target

USD 64.25
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

E.I. du Pont de Nemours & Co is a science and technology based company. It offers products and patents applications for agriculture, nutrition, electronics and communications, safety and protection, home and construction, transportation and others.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-14 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
SHW Sherwin-Williams Co

N/A

USD 79.21B
ECL Ecolab Inc

N/A

USD 66.73B
APD Air Products and Chemicals Inc

N/A

USD 58.82B
LYB LyondellBasell Industries NV

N/A

USD 31.72B
PPG PPG Industries Inc

N/A

USD 31.59B
DLY DoubleLine Yield Opportunities..

N/A

USD 27.84B
IFF International Flavors & Fragra..

N/A

USD 25.46B
WLK Westlake Chemical Corporation

N/A

USD 20.29B
AVTR Avantor Inc

N/A

USD 16.40B
ALB Albemarle Corp

N/A

USD 15.00B

ETFs Containing DD

ABEQ Absolute Core Strategy ET.. 5.32 % 0.00 %

N/A

USD 0.09B
BASE:CA Evolve Global Materials &.. 5.16 % 0.00 %

-0.03 (0.00%)

CAD 0.05B
BASE-B:CA Evolve Global Materials &.. 5.16 % 0.00 %

+0.24 (+0.00%)

CAD 0.08B
TINT ProShares Smart Materials.. 4.55 % 0.00 %

N/A

USD 1.70M
FRFD:LSE Franklin Future of Food U.. 4.19 % 0.00 %

N/A

USD 2.51M
RTM Invesco S&P 500® Equal W.. 3.81 % 0.40 %

N/A

USD 0.29B
RSPM Invesco S&P 500® Equal.. 3.62 % 0.00 %

N/A

USD 0.29B
XDRV:CA iShares Global Electric a.. 3.57 % 0.00 %

N/A

CAD 5.03M
XLPE:LSE Xtrackers LPX Private Equ.. 3.49 % 0.00 %

N/A

USD 0.37B
VCIT Vanguard Intermediate-Ter.. 0.10 % 0.07 %

N/A

USD 44.83B
SCHJ Schwab 1-5 Year Corporate.. 0.09 % 0.00 %

N/A

USD 0.40B
VCSH Vanguard Short-Term Corpo.. 0.08 % 0.07 %

N/A

USD 34.03B
VCLT Vanguard Long-Term Corpor.. 0.07 % 0.07 %

N/A

USD 8.71B
BIV Vanguard Intermediate-Ter.. 0.05 % 0.07 %

N/A

USD 17.27B
BLV Vanguard Long-Term Bond I.. 0.04 % 0.07 %

N/A

USD 5.54B
BSV Vanguard Short-Term Bond .. 0.02 % 0.07 %

N/A

USD 32.20B
IBDO 0.00 % 0.10 %

N/A

N/A
JHMA 0.00 % 0.47 %

N/A

N/A
RFCI RiverFront Dynamic Core I.. 0.00 % 0.51 %

N/A

USD 0.02B
BSUS:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.05B
SBM 0.00 % 0.95 %

N/A

N/A
SCHZ Schwab U.S. Aggregate Bon.. 0.00 % 0.04 %

N/A

USD 7.56B
SMN ProShares UltraShort Basi.. 0.00 % 0.95 %

N/A

USD 0.96M
UC97:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.19B
UC98:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.19B
SCHI Schwab 5-10 Year Corporat.. 0.00 % 0.00 %

N/A

USD 6.52B
LSAT Two Roads Shared Trust - .. 0.00 % 0.00 %

N/A

USD 0.14B

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.85% 44% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.85% 36% F 37% F
Trailing 12 Months  
Capital Gain 20.54% 61% D- 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.54% 54% F 62% D
Trailing 5 Years  
Capital Gain -6.65% 33% F 36% F
Dividend Return 4.00% 10% F 12% F
Total Return -2.65% 28% F 24% F
Average Annual (5 Year Horizon)  
Capital Gain 8.93% 57% F 67% D+
Dividend Return 10.06% 55% F 64% D
Total Return 1.13% 30% F 27% F
Risk Return Profile  
Volatility (Standard Deviation) 32.44% 57% F 34% F
Risk Adjusted Return 31.00% 57% F 53% F
Market Capitalization 61.52B 91% A- 92% A

Key Financial Ratios

  Ratio vs. Industry/Classification (Specialty Chemicals) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 30.70 2% 7%
Price/Book Ratio 1.27 76% 60%
Price / Cash Flow Ratio 15.03 31% 25%
Price/Free Cash Flow Ratio 17.69 16% 18%
Management Effectiveness  
Return on Equity 1.73% 18% 32%
Return on Invested Capital 5.24% 31% 45%
Return on Assets 2.65% 20% 52%
Debt to Equity Ratio 31.84% 90% 72%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector